Harvard Bioscience (HBIO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $7.96 -0.25%
Revenue Growth %: +6.1%
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.1%
Financial Fact:
Basic earnings per common share: -0.05
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $21.77 million versus the consensus estimate of $20 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing wins $20B U.S. Navy contract for sixth-generation fighter jet
- Carnival Corp. (CCL) Tops Q3 EPS by 8c
- General Dynamics wins two U.S. defense contracts totaling $121.2M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
